ARROWHEAD PHARMACEUTICALS, INC. - 10-K Filing

Arrowhead Pharmaceuticals reports fiscal year 2026 financial position and details extensive collaboration agreements with Sarepta, Novartis, Sanofi, and GSK.

SEC EDGAR ·

Tickers: $ARWR

Read the full article at SEC EDGAR

More Regulatory news